Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathwaysMitsuho Imai-Sumida, Soichiro Yamamura|Oncotarget|2017Cited by 63
444 Impact of homologous recombination deficiency on response to chemoimmunotherapy in biliary tract cancerOluseyi Abidoye, Tanios Bekaii‐Saab, Taro Shibuki et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0